Concepedia

Miaki Uzu

MU

Statistics

Publications

11

Citations

258

H-Index

11

Active since

2014

Affiliations

Chiba University(Current)

Tokyo University of Science

National Cancer Center Hospital East

Tsumura Research Institute (Japan)

National Cancer Research Institute

Miaki Uzu is an author at Chiba University specializing in oncology, medicine, and pharmacology.

Publications per year

2014–2022

11

Publications

11

Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells

Hiromi Sato, Sana Siddig, Miaki Uzu et al. · European Journal of Pharmacology · 2014 · 40 citations

Medicine, Oncology, Pharmacology +15

Intravenous administration of human mesenchymal stem cells derived from adipose tissue and umbilical cord improves neuropathic pain via suppression of neuronal damage and anti-inflammatory actions in rats

Kanako Miyano, Minori Ikehata, Kaori Ohshima et al. · PLoS ONE · 2022 · 34 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Connexin 43 enhances Bax activation via JNK activation in sunitinib-induced apoptosis in mesothelioma cells

Miaki Uzu, Hiromi Sato, Ayaka Shimizu et al. · Journal of Pharmacological Sciences · 2017 · 29 citations · Full text

Life Sciences, Oncology, Pharmacology +17

The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis

Kanako Miyano, Moeko Eto, Suzuro Hitomi et al. · Scientific Reports · 2020 · 29 citations · Full text

Medicine, Oncology, Pharmacology +14

Possible biased analgesic of hydromorphone through the G protein-over β-arrestin-mediated pathway: cAMP, CellKey™, and receptor internalization analyses

Sei Manabe, Kanako Miyano, Yuriko Fujii et al. · Journal of Pharmacological Sciences · 2019 · 26 citations · Full text

Medicine, Cell Biology, Pharmacology +17

1–5 of 11